Analysis
Nvidia has agreed to take minority stakes in French startups Doctolib and Genesis AI, the two companies confirmed Tuesday, as the chipmaker widens its push into European AI investment, according to a Reuters report carried by La Post. Neither company disclosed the size or value of the stake.
Doctolib operates an appointment-booking and telehealth platform used across France, Germany and Italy; the company said Nvidia's presence would help it develop AI tools, without elaborating further. Genesis AI, which the companies did not otherwise describe in Tuesday's disclosures, confirmed an earlier report from Les Echos. "We are excited that Nvidia is a strategic investor in Genesis AI," the company said in a statement.
“Genesis AI, which the companies did not otherwise describe in Tuesday's disclosures, confirmed an earlier report from Les Echos.”
Les Echos additionally reported that Nvidia bought stakes in French startups Entalpic and Pigment, though Reuters said neither company responded to requests for comment, leaving that part of the report unconfirmed.
The stakes extend a pattern Nvidia has run elsewhere: rather than only selling GPUs to AI-adjacent companies, it increasingly takes direct equity positions in them, aligning its own upside with the success of businesses building on its hardware -- a structure it has also used with cloud provider CoreWeave. For Doctolib, which has previously raised rounds valuing the company in the billions of dollars, Nvidia's involvement signals continued investor appetite for healthtech platforms layering AI onto existing clinical and scheduling workflows, even as neither the new valuation nor stake size was disclosed.
For founders in regulated European sectors like health data, the deal is a reminder that strategic corporate investors can move faster and more quietly than traditional venture rounds: Doctolib's statement offered no detail on governance rights, data-access terms, or board representation Nvidia may have negotiated as a condition of the stake. Until those terms surface, the announcement is confirmation of a relationship, not a template investors can yet evaluate.